Requirement for the Second Coding Exon of Tat in the Optimal Replication of Macrophage-Tropic HIV-1

HIV-1 Tat is essential for virus replication and is a potent transactivator of viral gene expression. Evidence suggests that Tat also influences virus infectivity and cytopathicity. Here, we find that the second coding exon of Tat contributes a novel function for the replication/infectivity of macrophage-tropic HIV-1. We show that macrophage-tropic HIV-1 which expresses the full-length two-exon form of Tat replicates better in monocyte-derived macrophages (MDM) than an otherwise isogenic virus which expresses only the one-exon form of Tat. Similarly, two-exon Tat expressing HIV-1 also replicates better than one-exon Tat expressing HIV-1 in two different models of human cells/tissue reconstituted SCID mice.

[1]  Z. Klase,et al.  An in Vivo Replication-important Function in the Second Coding Exon of Tat Is Constrained against Mutation despite Cytotoxic T Lymphocyte Selection* , 2003, Journal of Biological Chemistry.

[2]  T. Hahn,et al.  Evaluation of Genetic Diversity of Human Immunodeficiency Virus Type 1 nef Gene Associated with Vertical Transmission , 2003, Journal of Biomedical Science.

[3]  M. Giacca,et al.  HIV Tat, its TARgets and the control of viral gene expression. , 2003, FEMS microbiology letters.

[4]  K. Hsiao,et al.  Antibody reactivity to HIV-1 Vpu in HIV-1/AIDS patients on highly active antiretroviral therapy. , 2003, Journal of biomedical science.

[5]  Kuan-Teh Jeang,et al.  Tat and Trans-activation-responsive (TAR) RNA-independent Induction of HIV-1 Long Terminal Repeat by Human and Murine Cyclin T1 Requires Sp1* , 2003, The Journal of Biological Chemistry.

[6]  R. Siliciano,et al.  Latency in Human Immunodeficiency Virus Type 1 Infection: No Easy Answers , 2003, Journal of Virology.

[7]  K. Jeang,et al.  Small HIV-1-Tat peptides inhibit HIV replication in cultured T-cells. , 2003, Biochemical and biophysical research communications.

[8]  K. Jeang,et al.  Differential acetylation of Tat coordinates its interaction with the co‐activators cyclin T1 and PCAF , 2002, The EMBO journal.

[9]  J. Mak,et al.  Overexpression and Incorporation of GagPol Precursor Does Not Impede Packaging of HIV-1 tRNALys3 but Promotes Intracellular Budding of Virus-Like Particles , 2002, Journal of Biomedical Science.

[10]  R. Gallo.  Human retroviruses after 20 years: a perspective from the past and prospects for their future control , 2002, Immunological reviews.

[11]  K. Jeang,et al.  Damaged DNA and miscounted chromosomes: human T cell leukemia virus type I tax oncoprotein and genetic lesions in transformed cells. , 2002, Journal of biomedical science.

[12]  Stephen M. Smith.  HIV vaccine development in the nonhuman primate model of AIDS. , 2002, Journal of biomedical science.

[13]  I. Hewlett,et al.  Bcl-2 upregulation by HIV-1 Tat during infection of primary human macrophages in culture. , 2002, Journal of biomedical science.

[14]  M. Mathews,et al.  The Growth Factor Granulin Interacts with Cyclin T1 and Modulates P-TEFb-Dependent Transcription , 2002, Molecular and Cellular Biology.

[15]  K. Jeang,et al.  Constitutively Dead, Conditionally Live HIV-1 Genomes , 2001, The Journal of Biological Chemistry.

[16]  R. Gambari,et al.  Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA. , 2001, Antisense & nucleic acid drug development.

[17]  T. Rana,et al.  HIV-1 Tat Protein Interacts with Mammalian Capping Enzyme and Stimulates Capping of TAR RNA* , 2001, The Journal of Biological Chemistry.

[18]  N Bischofberger,et al.  Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  H. Xiao,et al.  Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Fauci,et al.  Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis , 2000, Immunological reviews.

[21]  D. Noonan,et al.  Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat. , 2000, Biochemical and biophysical research communications.

[22]  H. Schuitemaker,et al.  Pathogenesis of Primary R5 Human Immunodeficiency Virus Type 1 Clones in SCID-hu Mice , 2000, Journal of Virology.

[23]  H. Su,et al.  Human Immunodeficiency Virus Type 1 Pathogenesis in SCID-hu Mice Correlates with Syncytium-Inducing Phenotype and Viral Replication , 2000, Journal of Virology.

[24]  B. Williams,et al.  HIV-I TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms. , 2000, Archives of biochemistry and biophysics.

[25]  A. Burny,et al.  HIV‐1 Tat transcriptional activity is regulated by acetylation , 1999, The EMBO journal.

[26]  K. Jeang,et al.  Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat* , 1999, The Journal of Biological Chemistry.

[27]  M. Garber,et al.  HIV-1 Tat: coping with negative elongation factors. , 1999, Current opinion in immunology.

[28]  T. Rana,et al.  Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA. , 1999, Archives of biochemistry and biophysics.

[29]  K. Jeang,et al.  Epithelin/granulin growth factors: extracellular cofactors for HIV-1 and HIV-2 Tat proteins. , 1999, Biochemical and biophysical research communications.

[30]  T. Rana,et al.  Tat-associated Kinase (P-TEFb): a Component of Transcription Preinitiation and Elongation Complexes* , 1999, The Journal of Biological Chemistry.

[31]  M. Giacca,et al.  HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Rabin,et al.  HIV-1 Tat protein mimicry of chemokines. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  K. Jeang,et al.  Activation of Integrated Provirus Requires Histone Acetyltransferase , 1998, The Journal of Biological Chemistry.

[34]  K. Jeang,et al.  Modulation of Sp1 Phosphorylation by Human Immunodeficiency Virus Type 1 Tat , 1998, Journal of Virology.

[35]  H. Xiao,et al.  Interaction of the second coding exon of Tat with human EF-1 delta delineates a mechanism for HIV-1-mediated shut-off of host mRNA translation. , 1998, Biochemical and biophysical research communications.

[36]  Ping Wei,et al.  A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA , 1998, Cell.

[37]  H. Xiao,et al.  Promoter activity of Tat at steps subsequent to TATA-binding protein recruitment , 1997, Molecular and cellular biology.

[38]  C. Ambrosino,et al.  HIV-1 Tat Induces the Expression of the Interleukin-6 (IL6) Gene by Binding to the IL6 Leader RNA and by Interacting with CAAT Enhancer-binding Protein β (NF-IL6) Transcription Factors* , 1997, The Journal of Biological Chemistry.

[39]  D. Ho,et al.  Perspectives series: host/pathogen interactions. Dynamics of HIV-1 replication in vivo. , 1997, The Journal of clinical investigation.

[40]  R. Gaynor,et al.  Association of Tat with Purified HIV-1 and HIV-2 Transcription Preinitiation Complexes* , 1997, The Journal of Biological Chemistry.

[41]  C. Van Lint,et al.  Immune Hyperactivation of HIV-1-Infected T Cells Mediated by Tat and the CD28 Pathway , 1997, Science.

[42]  J. Coffin.  HIV viral dynamics. , 1996, AIDS.

[43]  K. Jeang,et al.  Requirements for RNA Polymerase II Carboxyl-terminal Domain for Activated Transcription of Human Retroviruses Human T-Cell Lymphotropic Virus I and HIV-1* , 1996, The Journal of Biological Chemistry.

[44]  J. Margolick,et al.  Selective transmission of human immunodeficiency virus type 1 variants to SCID mice reconstituted with human peripheral blood monoclonal cells , 1996, Journal of virology.

[45]  K. Jeang,et al.  Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture , 1996, Journal of virology.

[46]  K. Jeang,et al.  Conditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Gaynor,et al.  Human immunodeficiency virus type 1 and 2 Tat proteins specifically interact with RNA polymerase II. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[48]  G. Chinnadurai,et al.  Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator. , 1996, Virology.

[49]  A. Engelman,et al.  Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1 , 1995, Journal of virology.

[50]  A. Rice,et al.  Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor , 1995, Journal of virology.

[51]  P. Krammer,et al.  Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells , 1994, Journal of virology.

[52]  F. Buonaguro,et al.  The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure , 1994, Journal of virology.

[53]  F. Kashanchi,et al.  Direct interaction of human TFIID with the HIV-1 transactivator Tat , 1994, Nature.

[54]  B. Berkhout,et al.  Effects of integration and replication on transcription of the HIV-1 long terminal repeat. , 1993, The Journal of biological chemistry.

[55]  B. Berkhout,et al.  Kinetics of HIV-1 long terminal repeat trans-activation. Use of intragenic ribozyme to assess rate-limiting steps. , 1992, The Journal of biological chemistry.

[56]  B. Berkhout,et al.  TAR-independent activation of the HIV-1 LTR: Evidence that Tat requires specific regions of the promoter , 1990, Cell.

[57]  Jerome A. Zack,et al.  HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.

[58]  B. Berkhout,et al.  Tat trans-activates the human immunodeficiency virus through a nascent RNA target , 1989, Cell.

[59]  I. Weissman,et al.  Infection of the SCID-hu mouse by HIV-1. , 1988, Science.

[60]  K. Jeang,et al.  Transcriptional activation of homologous viral long terminal repeats by the human immunodeficiency virus type 1 or the human T-cell leukemia virus type I tat proteins occurs in the absence of de novo protein synthesis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[61]  H. Gendelman,et al.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.

[62]  J. Mak,et al.  Overexpression and incorporation of GagPol precursor does not impede packaging of HIV-1 tRNA(Lys3) but promotes intracellular budding of virus-like particles. , 2002, Journal of biomedical science.

[63]  R. Siliciano,et al.  The challenge of viral reservoirs in HIV-1 infection. , 2002, Annual review of medicine.

[64]  K. Jeang,et al.  A macrophage-tropic HIV-1 that expresses green fluorescent protein and infects alveolar and blood monocyte-derived macrophages. , 2002, Journal of biomedical science.

[65]  M. Churchill,et al.  Characterization of interactions between transcription factors and a regulatory region spanning nt -320 to -281 of the HIV-1 LTR in T-lymphoid and non-T-lymphoid cells. , 2002, Journal of biomedical science.

[66]  J. Farber,et al.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.

[67]  H. Gendelman,et al.  Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. , 1990, Annual review of immunology.

[68]  J. Enoch Powell,et al.  No easy answers , 1973 .